Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
---|---|---|---|---|---|---|---|---|---|---|
|
G | 0.700 | CausalMutation | CLINVAR | Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors. | 22588879 | 2012 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | MEK1 mutations confer resistance to MEK and B-RAF inhibition. | 19915144 | 2009 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors. | 22588879 | 2012 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. | 22197931 | 2011 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | MEK1 mutations confer resistance to MEK and B-RAF inhibition. | 19915144 | 2009 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma. | 23569304 | 2013 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. | 22197931 | 2011 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. | 22197931 | 2011 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | Melanoma genome sequencing reveals frequent PREX2 mutations. | 22622578 | 2012 |
|||
|
C | 0.700 | CausalMutation | CLINVAR | Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. | 22197931 | 2011 |